PM to meet vaccine makers today to discuss next phase of rollout

The Department of Biotechnology (DBT) is likely to make a presentation

Modi
PM Narendra Modi
IANS New Delhi
2 min read Last Updated : Apr 20 2021 | 2:33 PM IST

A day after announcing Covid vaccine for all above 18 years from May 1, Prime Minister Narendra Modi will meet the vaccine manufacturers on Tuesday evening through video conferencing.

Representatives of top drug makers from India and abroad, including companies whose vaccines have been approved by the government will attend the meeting scheduled at 6 p.m.

The Department of Biotechnology (DBT) is likely to make a presentation and also coordinate with all the participants of the meeting.

It is learnt that Prime Minister Modi called the meeting to discuss a plan for the next phase of vaccination starting May 1 in which everyone above 18 years is allowed to take the jab.

Till now, Indian drug regulators have approved two vaccines, 'Covidshield' manufactured by Serum Institute in India (SII) and 'Covaxin' by Bharat Biotech, for use in the country.

Drug regulators also approved Russian's 'Sputnik V' as the third vaccine marketed in the country by Dr Reddy's Laboratories. Other vaccines manufactured by global giants are also expected to be allowed in the country.

On Monday during a meeting chaired by Prime Minister Modi, an important decision of allowing vaccination to everyone above the age of 18 from May 1 was taken. Prime Minister Modi had also held discussions with doctors and representatives of pharma companies in separate meetings.

--IANS

ssb/dpb

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusNarendra ModiCoronavirus TestsCoronavirus Vaccine

First Published: Apr 20 2021 | 2:24 PM IST

Next Story